Home About us Current issue Back issues Submission Instructions Advertise Contact Login   

Search Article 
  
Advanced search 
 
Saudi Journal of Kidney Diseases and Transplantation
Users online: 325 Home Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size 


 
ORIGINAL ARTICLE Table of Contents   
Year : 2015  |  Volume : 26  |  Issue : 4  |  Page : 708-711
Spectrum of clinico-pathological profile and treatment response in children with nephrotic immunoglobulin a nephropathy


1 Department of Pediatric Nephrology, Sardar Vallabhbhai Patel Post Graduate Institute of Pediatrics, SCB Medical College, Cuttack, Odisha, India
2 Department of Pediatrics, Sardar Vallabhbhai Patel Post Graduate Institute of Pediatrics, SCB Medical College, Cuttack, Odisha, India

Correspondence Address:
Pradeep Sivaraj
Department of Pediatrics, Sardar Vallabhbhai Patel Post Graduate Institute of Pediatrics, SCB Medical College, Cuttack, Odisha
India
Login to access the Email id


DOI: 10.4103/1319-2442.160149

PMID: 26178542

Rights and Permissions

Immunoglobulin A nephropathy (IgAN) is one of the most common types of primary glomerulonephritis in the world. Nephrotic syndrome is an uncommon presentation of IgAN. To evaluate the clinico-pathological features and treatment response of nephrotic IgAN, we prospectively studied 20 nephrotic children with biopsy-proven IgAN at our center from August 2009 to December 2012. The histopathological characterization of IgAN was carried out with the HAAS classification. The demographic profile, clinical presentation, initial laboratory, biopsy findings and treatment response were analyzed. The mean age was 6.7 years. The most common indication of renal biopsy was steroid-dependent nephrotic syndrome associated with microscopic hematuria (65%) and hypertension (25%). The majority of cases were classified as HAAS-III stage. Fifteen cases responded to oral cyclosporine-A, four cases to oral cyclophosphamide and one to mycophenolate mofetil. Complete remission of the nephrotic syndrome was achieved in 90% (18/20) cases within 3 months of initiation of therapy. Two cases that had partial remission were in the HASS-II and III stages. We conclude that the majority of children with nephrotic IgAN responded to oral cyclosporine-A. However, a larger cohort and longer duration follow-up are required to confirm our results.


[FULL TEXT] [PDF]*
Print this article  Email this article
    

  Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   Citation Manager
  Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1324    
    Printed12    
    Emailed0    
    PDF Downloaded240    
    Comments [Add]    

Recommend this journal